Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

IVERIC Bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors

IVERIC bio, Inc. (NASDAQ: ISEE) announced today the election of Mark S. Blumenkranz, M.D., M.M.S., HJ Smead Professor Emeritus of Ophthalmology at Stanford University, to its Board of Directors, effective as of July 15, 2020. Dr. Blumenkranz is an internationally known vitreo-retinal specialist, with notable contributions in the area of novel pharmaceuticals for macular diseases, ocular gene therapy, new laser systems, and ophthalmic tele-health and technology development...

Mentions: Nasdaq Executive Chairman Stanford University